SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.48+0.8%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John F. Dowd who wrote (5934)10/13/1998 12:54:00 PM
From: Anthony Wong  Read Replies (1) of 9523
 
The AHP/MTC merger breakdown helps PFE, according to a Bloomberg article:

Helps Pfizer, Merck

The end of the merger helps Pfizer Inc. and Merck & Co.,
Keeney [analyst with ABN Amro] said.

Goldman, Sachs & Co. advised Monsanto, and Bear Stearns &
Co. advised American Home.

Monsanto earlier this year entered an agreement with rival
drugmaker Pfizer Inc., the maker of the impotence pill Viagra, to
help market its new arthritis painkiller. Monsanto is expected to
file this year with U.S. regulators for approval of the drug,
potentially its biggest seller.


Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext